Steward Partners Investment Advisory, LLC Oncternal Therapeutics, Inc. Transaction History

Steward Partners Investment Advisory, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$4.75 - $9.39 $33,250 - $65,730	-7,000 Reduced 95.89%	300 $1,000
Q1 2021 May 14, 2021	BUY	$4.59 - $9.04 $32,130 - $63,279	7,000 Added 2333.33%	7,300 $60,000
Q4 2020 Feb 11, 2021	BUY	$1.51 - $6.3 $453 - $1,890	300 New	300 $1,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.